Montecito Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,073
Closed -$316K 270
2021
Q4
$316K Hold
2,073
0.06% 229
2021
Q3
$335K Buy
+2,073
New +$349K 0.07% 213

Other funds holding IBB

Montecito Bank & Trust's IBB Position: Q1 2022 in Review

Montecito Bank & Trust sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 2,073 shares — an estimated $316K sold.

Montecito Bank & Trust first reported a position in IBB in Q3 2021 and held it in 2 quarters. The position peaked at $335K in Q3 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

  • Montecito Bank & Trust reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
  • Montecito Bank & Trust sold 2,073 iShares Biotechnology ETF shares in Q1 2022, an estimated $316K.
  • Montecito Bank & Trust first reported a position in iShares Biotechnology ETF in Q3 2021 and held it in 2 quarters.
  • Montecito Bank & Trust's iShares Biotechnology ETF position peaked at $335K in Q3 2021.
  • 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Montecito Bank & Trust's 13F filing for Q1 2022, filed 22 Apr 2022.